PMID- 12449035
OWN - NLM
STAT- MEDLINE
DCOM- 20021209
LR  - 20221207
IS  - 0007-4551 (Print)
IS  - 0007-4551 (Linking)
VI  - 89 Spec No
DP  - 2002 Aug
TI  - [Combinations of platinum salts and gemcitabine in the treatment of 
      non-small-cell lung cancer].
PG  - S80-4
AB  - Actually gemcitabine is a main drug in the treatment of non small cell lung 
      cancer (NSCLC). The doublet gemcitabine and cisplatin is a standard treatment, 
      widely used in the world. The review of the literature, and specially several 
      recent randomised phase III trial in stage IV NSCLC demonstrates the 
      reproducibility of the results, and a manageable toxicity which allows its use in 
      preoperative setting in stages I, II and resectable III. The 
      carboplatin-gemcitabine doublet is under investigation.
FAU - Souquet, Pierre-Jean
AU  - Souquet PJ
AD  - Hospices civils de Lyon, Centre hospitalier Lyon-Sud, 69495 Pierre-Benite. 
      pierre-jean.souquet@chu-lyon.fr
FAU - Geriniere, Laurence
AU  - Geriniere L
LA  - fre
PT  - Comparative Study
PT  - Journal Article
PT  - Review
TT  - Les associations sels de platine-gemcitabine dans les traitements des cancers 
      bronchiques non a petites cellules.
PL  - France
TA  - Bull Cancer
JT  - Bulletin du cancer
JID - 0072416
RN  - 0 (Taxoids)
RN  - 0W860991D6 (Deoxycytidine)
RN  - 15H5577CQD (Docetaxel)
RN  - 5V9KLZ54CY (Vinblastine)
RN  - 6PLQ3CP4P3 (Etoposide)
RN  - BG3F62OND5 (Carboplatin)
RN  - P88XT4IS4D (Paclitaxel)
RN  - Q20Q21Q62J (Cisplatin)
RN  - Q6C979R91Y (Vinorelbine)
RN  - 0 (Gemcitabine)
SB  - IM
MH  - Antineoplastic Combined Chemotherapy Protocols/adverse effects/*therapeutic use
MH  - Carboplatin/administration & dosage/adverse effects
MH  - Carcinoma, Non-Small-Cell Lung/*drug therapy/surgery
MH  - Cisplatin/administration & dosage/adverse effects
MH  - Clinical Trials, Phase III as Topic
MH  - Combined Modality Therapy
MH  - Deoxycytidine/administration & dosage/adverse effects/*analogs & derivatives
MH  - Docetaxel
MH  - Etoposide/administration & dosage/adverse effects
MH  - Gastrointestinal Diseases/chemically induced
MH  - Hematologic Diseases/chemically induced
MH  - Humans
MH  - Lung Neoplasms/drug therapy/*surgery
MH  - Neoadjuvant Therapy
MH  - Paclitaxel/administration & dosage/adverse effects/*analogs & derivatives
MH  - Pneumonectomy
MH  - Randomized Controlled Trials as Topic
MH  - Remission Induction
MH  - Reproducibility of Results
MH  - *Taxoids
MH  - Treatment Outcome
MH  - Vinblastine/administration & dosage/adverse effects/*analogs & derivatives
MH  - Vinorelbine
MH  - Gemcitabine
RF  - 20
EDAT- 2002/11/27 04:00
MHDA- 2002/12/10 04:00
CRDT- 2002/11/27 04:00
PHST- 2002/11/27 04:00 [pubmed]
PHST- 2002/12/10 04:00 [medline]
PHST- 2002/11/27 04:00 [entrez]
PST - ppublish
SO  - Bull Cancer. 2002 Aug;89 Spec No:S80-4.